Suppr超能文献

Crucial role of histone deacetylase SIRT1 in myeloid-derived suppressor cell-mediated reprogramming of CD4 T-cell differentiation.

作者信息

Dong Lin, Bi Yujing, Jia Anna, Yu Qing, Wang Yuexin, Wang Yufei, Yang Qiuli, Cao Yejin, He Ying, Liu Ruichen, Li Yan, Liu Guangwei

机构信息

Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, Institute of Cell Biology, College of Life Sciences, Beijing Normal University, 100875, Beijing, China.

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, 100071, Beijing, China.

出版信息

Cell Mol Immunol. 2020 Jul;17(7):785-787. doi: 10.1038/s41423-020-0419-6. Epub 2020 Apr 7.

Abstract
摘要

相似文献

1
Crucial role of histone deacetylase SIRT1 in myeloid-derived suppressor cell-mediated reprogramming of CD4 T-cell differentiation.
Cell Mol Immunol. 2020 Jul;17(7):785-787. doi: 10.1038/s41423-020-0419-6. Epub 2020 Apr 7.
2
SIRT1 and HIF1α signaling in metabolism and immune responses.
Cancer Lett. 2018 Apr 1;418:20-26. doi: 10.1016/j.canlet.2017.12.035. Epub 2018 Jan 4.
3
In Vitro Suppression of CD4 T-Cell Responses by Murine and Human Myeloid-Derived Suppressor Cells.
Methods Mol Biol. 2019;1899:119-128. doi: 10.1007/978-1-4939-8938-6_9.
4
Histone Deacetylase SIRT1 Negatively Regulates the Differentiation of Interleukin-9-Producing CD4(+) T Cells.
Immunity. 2016 Jun 21;44(6):1337-49. doi: 10.1016/j.immuni.2016.05.009. Epub 2016 Jun 14.
5
Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming.
Ageing Res Rev. 2018 May;43:64-80. doi: 10.1016/j.arr.2018.02.004. Epub 2018 Feb 21.
9
Myeloid-derived suppressor cells suppress CD4+ T cell activity and prevent the development of type 2 diabetes.
Acta Biochim Biophys Sin (Shanghai). 2018 Apr 1;50(4):362-369. doi: 10.1093/abbs/gmy014.
10
Sox2 Deacetylation by Sirt1 Is Involved in Mouse Somatic Reprogramming.
Stem Cells. 2015 Jul;33(7):2135-47. doi: 10.1002/stem.2012. Epub 2015 May 4.

引用本文的文献

1
MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy.
Cancer Gene Ther. 2025 Apr;32(4):371-392. doi: 10.1038/s41417-025-00886-9. Epub 2025 Mar 26.
2
The role and therapeutic potential of SIRTs in sepsis.
Front Immunol. 2024 Apr 16;15:1394925. doi: 10.3389/fimmu.2024.1394925. eCollection 2024.
3
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy.
Mil Med Res. 2023 Dec 4;10(1):59. doi: 10.1186/s40779-023-00496-2.
4
Advances in Immunomodulatory Mechanisms of Mesenchymal Stem Cells-Derived Exosome on Immune Cells in Scar Formation.
Int J Nanomedicine. 2023 Jul 3;18:3643-3662. doi: 10.2147/IJN.S412717. eCollection 2023.
6
SIRT1 single-nucleotide polymorphisms are associated with corticosteroid sensitivity in primary immune thrombocytopenia patients.
Ann Hematol. 2021 Oct;100(10):2453-2462. doi: 10.1007/s00277-021-04583-z. Epub 2021 Jul 16.
7
Metabolic reprogramming of myeloid-derived suppressor cells: An innovative approach confronting challenges.
J Leukoc Biol. 2021 Aug;110(2):257-270. doi: 10.1002/JLB.1MR0421-597RR. Epub 2021 Jun 2.
8
Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy.
Cancers (Basel). 2020 Sep 15;12(9):2626. doi: 10.3390/cancers12092626.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验